OVERSEA CHINESE BANKING Corp Ltd Sells 3,952 Shares of The Allstate Co. (NYSE:ALL)

OVERSEA CHINESE BANKING Corp Ltd lowered its stake in The Allstate Co. (NYSE:ALL - Free Report) by 53.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,467 shares of the insurance provider's stock after selling 3,952 shares during the period. OVERSEA CHINESE BANKING Corp Ltd's holdings in Allstate were worth $658,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ALL. WealthPlan Investment Management LLC bought a new stake in shares of Allstate during the 3rd quarter valued at $208,000. Harbour Investments Inc. grew its holdings in shares of Allstate by 5.4% in the 3rd quarter. Harbour Investments Inc. now owns 2,503 shares of the insurance provider's stock valued at $475,000 after buying an additional 128 shares during the period. Entropy Technologies LP acquired a new position in shares of Allstate in the 3rd quarter valued at $284,000. Apollon Wealth Management LLC grew its holdings in shares of Allstate by 2.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 5,901 shares of the insurance provider's stock valued at $1,119,000 after buying an additional 157 shares during the period. Finally, Versor Investments LP acquired a new position in shares of Allstate in the 3rd quarter valued at $1,955,000. Institutional investors and hedge funds own 76.47% of the company's stock.

Insider Buying and Selling

In related news, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company's stock, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business's stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares of the company's stock, valued at $5,236,922.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Toohey sold 16,682 shares of the business's stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the transaction, the executive vice president now directly owns 4,873 shares of the company's stock, valued at approximately $877,968.41. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 192,530 shares of company stock valued at $34,967,665. Company insiders own 1.80% of the company's stock.

Allstate Stock Performance

Shares of NYSE ALL traded down $1.83 during midday trading on Thursday, hitting $195.47. The company's stock had a trading volume of 312,005 shares, compared to its average volume of 1,540,136. The stock has a fifty day moving average price of $189.58 and a 200 day moving average price of $176.40. The Allstate Co. has a one year low of $130.77 and a one year high of $201.00. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $51.76 billion, a price-to-earnings ratio of 12.69, a P/E/G ratio of 1.77 and a beta of 0.48.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same quarter in the previous year, the firm posted $0.81 earnings per share. The company's quarterly revenue was up 14.7% compared to the same quarter last year. On average, research analysts forecast that The Allstate Co. will post 16.02 EPS for the current fiscal year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 1.88%. Allstate's dividend payout ratio (DPR) is presently 23.83%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. UBS Group upped their target price on shares of Allstate from $216.00 to $225.00 and gave the stock a "buy" rating in a research note on Monday, November 4th. Jefferies Financial Group upped their target price on shares of Allstate from $231.00 to $267.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. Roth Mkm reissued a "buy" rating and set a $200.00 price target on shares of Allstate in a research report on Wednesday, August 14th. Evercore ISI boosted their price target on shares of Allstate from $191.00 to $195.00 and gave the stock an "in-line" rating in a research report on Wednesday, October 9th. Finally, Wells Fargo & Company boosted their price target on shares of Allstate from $175.00 to $186.00 and gave the stock an "equal weight" rating in a research report on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Allstate has an average rating of "Moderate Buy" and a consensus target price of $212.56.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.